The Excedr Blog
Enhance your lab operations and funding strategies with actionable advice on equipment leasing, financing, procurement, and life sciences industry trends.
Pelage Pharmaceuticals: Pioneering Stem Cell Therapy for Hair Loss
Pelage Pharmaceuticals raises $120M Series B for PP405 stem cell therapy in hair loss—Excedr covers this major biotech funding round.
October 2025
Peptilogics: Using AI-Powered Peptides to Combat Prosthetic Joint Infections
Peptilogics raises $78M to develop AI-designed peptides for joint infections—Excedr covers this major biotech funding round.
October 2025
Weave Bio: AI-Powered Regulatory Automation for Drug Development
Weave Bio’s $20M Series A accelerates AI automation in drug regulatory workflows—Excedr covers this major biotech funding round.
October 2025
Exactics: Building a Universal Platform for Rapid Infectious Disease Testing
Exactics pioneers rapid, at-home infectious disease tests with its adaptable Proteus+ platform—Excedr covers this major biotech funding round.
October 2025
Lila Sciences Builds Scientific Superintelligence Through Autonomous AI Labs
Lila Sciences pioneers autonomous AI labs, raising $550M to build scientific superintelligence—Excedr covers this major biotech funding round.
October 2025
Kailera Therapeutics Raises $1 Billion to Challenge the Obesity Market
Kailera Therapeutics raises $1B to advance KAI-9531 obesity drug—Excedr covers this major biotech funding round.
October 2025
Expedition Therapeutics Raises Funds to Target COPD
Expedition Therapeutics secures $165M Series A to advance EXPD-101, a first-in-class oral DPP-1 inhibitor for COPD—Excedr covers this major biotech funding round.
October 2025
Lumen Bioscience: Revolutionizing Biologic Drug Manufacturing with Spirulina
Lumen Bioscience pioneers affordable oral biologic drugs using engineered spirulina—Excedr covers this major biotech funding round.
October 2025
